Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11008399 Antibodies

Patent 11008399 was granted and assigned to Genmab A/S on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Rik Rademaker0

Sjeng Horbach0

Bart E. C. G. De Goeij0

David Satijn0

Dennis Verzijl0

Edward N. Van Den Brink0

Esther C. W. Breij0

Kristel Kemper0

...

Date of Patent

May 18, 2021

Patent Application Number

17077376

Date Filed

October 22, 2020

Patent Citations

US Patent 10590206 Inert format

US Patent 10344050 Production of heterodimeric proteins

0

US Patent 10407501 Humanized or chimeric CD3 antibodies

0

US Patent 10434184 Anti-TPBG antibodies and methods of use

0

US Patent 10465006 Humanized or chimeric CD3 antibodies

US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof

Patent Citations Received

US Patent 11970544 Antibodies

0

Patent Primary Examiner

Jessica H Roark

Patent abstract

The present invention relates to antibodies binding to 5T4, including bispecific antibodies binding to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11008399 Antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool